T80.51 Anaphylactic reaction due to administration of blood and blood products

Name of the Condition

• Anaphylactic reaction due to administration of blood and blood products.

Summary

This condition describes a severe, life-threatening allergic reaction that occurs after receiving blood or blood products. It involves a rapid systemic response affecting multiple organ systems, requiring immediate medical intervention.

Causes

Anaphylactic reactions may result from exposure to allergens present in blood or blood products, such as plasma proteins, antibodies, or other components. These reactions are triggered by the immune system's overreaction to specific substances in the transfused material.

Risk Factors

• Prior history of allergic reactions to blood products
• Known allergies to components in blood (e.g., IgA, plasma proteins)
• Receiving blood products from donors with incompatible antigens
• Underlying immune system disorders
• Repeated transfusions increasing sensitization risk

Symptoms

• Sudden onset of hives, itching, or widespread rash
• Swelling of the lips, tongue, or throat
• Difficulty breathing or wheezing
• Rapid heartbeat or palpitations
• Dizziness, fainting, or loss of consciousness
• Nausea, vomiting, or abdominal cramps
• Drop in blood pressure (hypotension)

Diagnosis

Diagnosis is based on clinical presentation and timing relative to blood product administration. Healthcare providers assess symptoms, review transfusion history, and may perform tests to rule out other causes. Documentation of the reaction's onset and severity is essential.

Treatment Options

Immediate treatment includes epinephrine administration, oxygen therapy, and intravenous fluids to stabilize blood pressure. Antihistamines and corticosteroids may be used to manage symptoms. In severe cases, advanced life support and monitoring in a critical care setting are necessary.

Prognosis and Follow-Up

With prompt treatment, most patients recover fully. Follow-up care involves monitoring for delayed reactions and evaluating the need for future blood product precautions. Long-term management may include pre-transfusion testing or specialized blood products to prevent recurrence.

Complications

• Respiratory failure requiring mechanical ventilation
• Cardiovascular collapse or shock
• Permanent organ damage from prolonged hypoxia
• Death in severe, untreated cases

Lifestyle & Prevention

• Inform healthcare providers of any known allergies before transfusions
• Use of leukoreduced or washed blood products in high-risk patients
• Pre-medication with antihistamines or corticosteroids in select cases
• Avoidance of unnecessary blood product transfusions

When to Seek Professional Help

Seek immediate medical attention if symptoms of anaphylaxis occur during or after a blood transfusion, including difficulty breathing, swelling, or dizziness. Do not wait for symptoms to worsen.

Tips for Medical Coders

Document the specific blood product involved, timing of the reaction, and clinical interventions. Ensure clear linkage between the transfusion and the anaphylactic event. Code T80.51 is appropriate when the reaction is directly attributable to blood or blood product administration.